Neuroblastoma and Ewing's Sarcoma Associated with ROR1 Expression Can Be Effectively Targeted with NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor

被引：6
|
作者：
Elmacken, Mona [1 ]
Awasthi, Aradhana [1 ]
Ayello, Janet [1 ]
van de Ven, Carmella [1 ]
Luo, Wen [1 ]
Liao, Yanling [1 ]
Riddell, Stanley [2 ]
Cairo, Mitchell S. [1 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2014.11.117
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
94
引用
收藏
页码：S95 / S97
页数：3
相关论文
共 41 条
  • [1] Neuroblastoma (NB), Medulloblastoma (MB), and Ewing's sarcoma (ES) express ROR1 and can be effectively targeted with NK cells modified to express an anti ROR1 chimeric antigen receptor (CAR)
    Elmacken, Mona
    Awasthi, Aradhana
    Ayello, Janet
    VanDeVen, Carmella
    Luo, Wen
    Liao, Yanling
    Riddell, Stanley
    Cairo, Mitchell S.
    [J]. CANCER RESEARCH, 2015, 75
  • [2] ROR1 EXPRESSING NEUROBLASTOMA (NB), MEDULLOBLASTOMA (MB), AND EWING'S SARCOMA (ES) CAN BE EFFECTIVELY TARGETED WITH NK CELLS MODIFIED TO EXPRESS AN ANTI ROR1 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Elmacken, M.
    Awasthi, A.
    Ayello, J.
    van de Ven, C.
    Luo, W.
    Liao, Y.
    Riddell, S.
    Cairo, M.
    [J]. CYTOTHERAPY, 2015, 17 (06) : S48 - S48
  • [3] ROR1 EXPRESSING NEUROBLASTOMA (NB), MEDULLOBLASTOMA (MB), AND EWING'S SARCOMA (ES) CAN BE EFFECTIVELY TARGETED WITH NK CELLS MODIFIED TO EXPRESS AN ANTI-ROR1 CHIMERIC ANTIGEN RECEPTOR (CAR)
    Elmacken, Mona
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : 112 - 112
  • [4] The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
    Hudecek, Michael
    Schmitt, Thomas M.
    Baskar, Sivasubramanian
    Lupo-Stanghellini, Maria Teresa
    Nishida, Tetsuya
    Yamamoto, Tori N.
    Bleakley, Marie
    Turtle, Cameron J.
    Chang, Wen-Chung
    Greisman, Harvey A.
    Wood, Brent
    Maloney, David G.
    Jensen, Michael C.
    Rader, Christoph
    Riddell, Stanley R.
    [J]. BLOOD, 2010, 116 (22) : 4532 - 4541
  • [5] Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
    Berger, Carolina
    Sommermeyer, Daniel
    Hudecek, Michael
    Berger, Michael
    Balakrishnan, Ashwini
    Paszkiewicz, Paulina J.
    Kosasih, Paula L.
    Rader, Christoph
    Riddell, Stanley R.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (02) : 206 - 216
  • [6] A novel ROR1 chimeric antigen receptor for the treatment of haematological and solid malignancies
    Gohil, S. H.
    Della Peruta, M.
    Paredes, S.
    Harrasser, M.
    Cheung, G. W.
    Davies, D. M.
    Pule, M.
    Nathwani, A. C.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A82 - A82
  • [7] Optimization of Third Generation Chimeric Antigen Receptor T Cells Targeting ROR1 for Hematological Malignancies
    Cortes, Eider F. Moreno
    Robledo, Juan Esteban Garcia
    Booth, Natalie
    Forero, Jose V.
    Castro, Januario E.
    [J]. BLOOD, 2021, 138
  • [8] CD8+ T Cells Engineered to Express a ROR1-Specific Chimeric Antigen Receptor Specifically Recognize ROR1 Positive B Cell Tumors
    Hudecek, Michael
    Schmitt, Thomas M.
    Baskar, Sivasubramanian
    Chang, Wen-Chung
    Maloney, David G.
    Jensen, Michael C.
    Rader, Christoph M.
    Riddell, Stanley
    [J]. BLOOD, 2009, 114 (22) : 383 - 383
  • [9] Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy
    Zhang, Suping
    Cui, Bing
    Lai, Hsien
    Liu, Grace
    Ghia, Emanuela M.
    Widhopf, George F.
    Zhang, Zhuhong
    Wu, Christina C. N.
    Chen, Liguang
    Wu, Rongrong
    Schwab, Richard
    Carson, Dennis A.
    Kipps, Thomas J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (48) : 17266 - 17271
  • [10] The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer
    Meng, Shangsen
    Li, Ming
    Qin, Le
    Lv, Jiang
    Wu, Di
    Zheng, Diwei
    Jia, Heng
    Chen, Dongmei
    Wu, Qiting
    Long, Youguo
    Tang, Zhaoyang
    Tang, Yanlai
    Yang, Lihua
    Yao, Yao
    Luo, Xuequn
    Li, Peng
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
12345